The pipeline is bursting with them – the potential blockbuster co-productions with their eyes on the Chinese box office that is nowadays counted in hundreds of millions of yuan.
Emperor Motion Picture's 200 million yuan-costing December 2010 release Shaolin, starring Andy Lau and Jackie Chan, Media Asia's biopic Bruce Lee My Brother, due for end of this month, Peter Chan's Us$20 million directorial outing Wu Xia, featuring Donnie Yen and Takeshi Kaneshiro in the leads (for late 2011), or the 400-million-yuan 3D fantasy The Monkey King and the remake of A Chinese Odyssey, Filmko and Stephen Chow's different takes on the Chinese literary classic Journey to the West, These are among some of the eyeball-drawing upcoming titles that serves as examples of what is now called "Greater China films."
However, in Hong Kong, new investors are surfacing and trying to capitalize on the atmosphere of diversity in the local marketplace, bringing with...
Emperor Motion Picture's 200 million yuan-costing December 2010 release Shaolin, starring Andy Lau and Jackie Chan, Media Asia's biopic Bruce Lee My Brother, due for end of this month, Peter Chan's Us$20 million directorial outing Wu Xia, featuring Donnie Yen and Takeshi Kaneshiro in the leads (for late 2011), or the 400-million-yuan 3D fantasy The Monkey King and the remake of A Chinese Odyssey, Filmko and Stephen Chow's different takes on the Chinese literary classic Journey to the West, These are among some of the eyeball-drawing upcoming titles that serves as examples of what is now called "Greater China films."
However, in Hong Kong, new investors are surfacing and trying to capitalize on the atmosphere of diversity in the local marketplace, bringing with...
- 11/4/2010
- The Hollywood Reporter - Movie News
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.